Login to Your Account

AI meets I-O: Evotec invests in Exscientia for drug discovery

By Nuala Moran
Staff Writer

Thursday, September 28, 2017

LONDON – Europe's drug discovery supremo, Evotec AG has nailed its colors to the AI mast, making a €15 million (US$17.6 million) investment in artificial intelligence specialist Exscientia Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription